Page 499 - O_Desenvolvimento_do_Autismo
P. 499
DANYSZ, W. “CX-516 Cortex pharmaceuticals”. Current Opinion in
Investigational Drugs 3(7), 2002, pp. 1.081-1.088.
DAWSON, G. e LEVY, A. “Arousal, attention and the socioemotional
adjustment of individuals with autism”. In: G. Dawson (ed.). Autism: nature,
diagnosis and treatment. Nova York: Guilford, 1989.
DAY, J. D.; CORDON, L. A. e KERWIN, M. L. “Informal instruction and
development of cognitive skills: a review and critique of research”. In: C. B.
McCormick; G. Miller e M. Pressley (eds.). Cognitive strategy research:
from basic research to educational applications. Nova York: Springer-
Verlag, 1989.
DELGIUDICE-ASCH, G.; SIMON, L.; SCHMEIDLER, J.; CUNNINGHAM-
RUNDLES, C. e HOLLANDER, E. “Brief report: a pilot open clinical trial
of intravenous immunoglobulin in childhood autism”. Journal of Autism and
Developmental Disorders 29, 1999, pp. 157-160.
DENHAM, S.; BLAIR, K.; DEMULDER, E.; LEVITAS, J.; SAWYER, K.;
AUERBACH-MAJOR, S. e QUEENAN, P. “Preschool emotional
competence: pathway to social competence”. Child Development 74, 2003,
pp. 238-256.
D’EUFEMIA, P.; CELLI, M.; FINOCCHIARO, R.; PACIFICO, L.; VIOZZI,
L.; ZACCAGNINI, M.; CARDI, E. e GIARDINI, O. “Abnormal intestinal
permeability in children with autism”. Acta Paediatrica 85(9), 1996, pp.
1.076-1.079.

